Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05989308 · ClinicalTrials.gov registry record · NA
MyChart Proxy Outreach to Parents (MyPOP)
A NA study of Health Technology, sponsored by Yale University.
- Recruiting
- Registry status
- NA
- Development phase
- 5,200
- Enrollment target
- 4
- Study locations
NCT05989308 is a NA study of Health Technology that is actively recruiting participants, run by Yale University. The registered enrollment target is 5,200 participants. The trial reports 4 study locations across 1 state.
The verdict
NCT05989308, a NA study of Health Technology, is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- NA
- Development phase
- 5,200 participants
- Enrollment target
- 4
- Study locations
Study Summary
The goal of this randomized controlled trial is to assess the extent to which different modes of contacting parents who have not yet enabled to access to their children's medical records will result in greater proxy access. The main questions the study aims to answer are: * will outreach via text or patient portal message result in more parents having access than usual care (which is in-office suggestions to get access). * which mode - text or portal - will get more parents access. Participants will get a text message, or a portal message through their own patient portal, or no message. The investigators will check access to see which group has increased more during the study period.
Conditions Studied
Interventions
- BEHAVIORAL Email
- BEHAVIORAL Text
- BEHAVIORAL Patient Portal Message
Study Locations (4)
Connecticut
- Cornell Scott Hill Health Center - New Haven
- Fair Haven Community Health Center - New Haven
- Yale New Haven Health - New Haven
- Yale School of Medicine - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,200 participants |
| Start Date | 2024-10-15 |
| Est. Completion | 2026-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05989308
The ClinicalTrials.gov registry entry for NCT05989308 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 5,200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Health Technology appearing as the primary indexed condition, and to 3 interventions - of which Email is the first listed.
NCT05989308 reports 4 study locations spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT05989308 about?
NCT05989308 is a clinical study titled "MyChart Proxy Outreach to Parents (MyPOP)". The goal of this randomized controlled trial is to assess the extent to which different modes of contacting parents who have not yet enabled to access to their children's medical records will result in greater proxy access. The main questions the study aims to answer are: * will outreach via text o...
What is the current status of trial NCT05989308?
This trial is currently recruiting. It is a NA study. The enrollment target is 5,200 participants. The study started on 2024-10-15. Estimated completion is 2026-09.
What conditions does trial NCT05989308 study?
This clinical trial studies the following conditions: Health Technology.
What interventions are being tested in trial NCT05989308?
The interventions under investigation include: Email (BEHAVIORAL), Text (BEHAVIORAL), Patient Portal Message (BEHAVIORAL).
Who is sponsoring clinical trial NCT05989308?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05989308 being conducted?
This trial has 4 study locations across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.